Cite
HARVARD Citation
Amorosa, V. et al. (2013). Addition of Nitazoxanide to PEG-IFN and Ribavirin to Improve HCV Treatment Response in HIV-1 and HCV Genotype 1 Coinfected Persons Naïve to HCV Therapy: Results of the ACTG A5269 Trial. HIV clinical trials. 14 (6), pp. 274-283. [Online].